Tirzepatide Associated With Improved Health‐Related Quality of Life in Adults With Obesity or Overweight in <scp>SURMOUNT</scp> ‐4

Authors

Institutions

Publication Details

Journal
Obesity
Published
2025-09-03
DOI
https://doi.org/10.1002/oby.70011
Citations
1
Primary Topic
Pharmacology and Obesity Treatment
Type
article
Field-Weighted Citation Impact
1.39

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Tirzepatide Associated With Improved Health‐Related Quality of Life in Adults With Obesity or Overweight in SURMOUNT ‐4

Theresa Hunter, Harold Edward Bays, Dachuang Cao, Birong Liao et al.
1 citations
Obesity
Pharmacology and Obesity Treatment
1.39
article

Tirzepatide Associated With Improved Health‐Related Quality of Life in Adults With Obesity or Overweight in SURMOUNT ‐4

Theresa Hunter, Harold Edward Bays, Dachuang Cao, Birong Liao, Irina Jouravskaya, Madhumita Murphy
article en
1 citations

Abstract

No abstract available for this paper.
ObesityVol. 33(11)
Eli Lilly (United States) (US), Louisville Metabolic and Atherosclerosis Research Center (US)
Eli Lilly and Company
Openalex Percentile: Top 16%
Pharmacology and Obesity Treatment
1.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.